Meridiem Investment Management Ltd. Has $298.14 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Meridiem Investment Management Ltd. lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.9% during the fourth quarter, Holdings Channel reports. The firm owned 571,119 shares of the medical equipment provider’s stock after selling 70,188 shares during the period. Intuitive Surgical makes up approximately 5.3% of Meridiem Investment Management Ltd.’s investment portfolio, making the stock its 6th biggest position. Meridiem Investment Management Ltd.’s holdings in Intuitive Surgical were worth $298,143,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Bennett Selby Investments LP raised its stake in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after purchasing an additional 17 shares during the period. LVW Advisors LLC raised its position in Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after acquiring an additional 19 shares during the period. Wesbanco Bank Inc. raised its position in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after acquiring an additional 19 shares during the period. Journey Strategic Wealth LLC boosted its stake in Intuitive Surgical by 1.9% in the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock valued at $542,000 after acquiring an additional 19 shares during the last quarter. Finally, FSM Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after purchasing an additional 19 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of several research reports. Barclays increased their price objective on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Jefferies Financial Group upped their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Truist Financial lifted their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Up 0.7 %

NASDAQ:ISRG opened at $595.55 on Monday. The stock has a market cap of $212.12 billion, a P/E ratio of 92.91, a PEG ratio of 5.67 and a beta of 1.39. The business’s 50-day moving average price is $559.48 and its two-hundred day moving average price is $519.66. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Insider Buying and Selling

In other news, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 6,348 shares of company stock worth $3,587,582. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.